<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
BIOMATRIX, INC. FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 46,700
<SECURITIES> 0
<RECEIVABLES> 12,600
<ALLOWANCES> 0
<INVENTORY> 8,200
<CURRENT-ASSETS> 73,300
<PP&E> 39,700
<DEPRECIATION> 0
<TOTAL-ASSETS> 113,800
<CURRENT-LIABILITIES> 11,300
<BONDS> 11,100
0
0
<COMMON> 0
<OTHER-SE> 91,400
<TOTAL-LIABILITY-AND-EQUITY> 113,800
<SALES> 57,300
<TOTAL-REVENUES> 66,400
<CGS> 17,100
<TOTAL-COSTS> 45,500
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 700
<INCOME-PRETAX> 22,500
<INCOME-TAX> 9,200
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 13,300
<EPS-BASIC> 0.57
<EPS-DILUTED> 0.55
</TABLE>